Pugoy, Manilyn .
HRN: 25-07-89 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/24/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
05/24/2024
05/26/2024
IV
Q8 6 Doses
Q8
Sp Pelvic Lap
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominalCentral Nervous System Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes